Latest news
NUVL Stock Surges 39% Premarket – Why Is GSK Buying This Boston-Based Oncology Company? - StocktwitsStocktwits · Fri, 07 Aug 2026 04:32:10 GMTGSK partner Hansoh reports another phase 3 win for priority ADC - Fierce BiotechFierce Biotech · Tue, 28 Jul 2026 12:20:00 GMTGSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain - Fierce PharmaFierce Pharma · Tue, 28 Jul 2026 07:00:00 GMTGSK lays out plans to cut costs, pursue more late-stage drug trials - STATSTAT · Tue, 28 Jul 2026 07:00:00 GMTGSK prepares for patent cliff with $2.5B cost-cutting plan - BioPharma DiveBioPharma Dive · Tue, 28 Jul 2026 07:00:00 GMTUpdated: GSK reveals three-year blueprint to cut costs and propel R&D - Endpoints NewsEndpoints News · Tue, 28 Jul 2026 07:00:00 GMTGSK Earnings Preview: EPS to take a plunge; CEO's comments, guidance in focus - Seeking AlphaSeeking Alpha · Mon, 27 Jul 2026 07:00:00 GMT